Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer
Abstract Given that only a subset of patients with colorectal cancer (CRC) benefit from immune checkpoint therapy, efforts are ongoing to identify markers that predict immunotherapeutic response. Increasing evidence suggests that microbes influence the efficacy of cancer therapies. Fusobacterium nuc...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Publishing Group
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/590c41649479464395ada50dedae6436 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|